Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups by Whitaker, HJ, Tsang, RSM, Byford, R, Andrews, NJ, Sherlock, J, Sebastian Pillai, P, Williams, J, Button, E, Campbell, H, Sinnathamby, M, Victor, W, Anand, S, Linley, E, Hewson, J, DArchangelo, S, Otter, AD, Ellis, J, Hobbs, RFD, Howsam, G, Zambon, M, Ramsay, M, Brown, KE, de Lusignan, S, Amirthalingam, G, Lopez Bernal, J

COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study by Whitaker, HJ, Tsang, RSM, Byford, R, Aspden, C, Button, E, Sebastian Pillai, P, Jamie, G, Kar, D, Williams, J, Sinnathamby, M, Marsden, G, Elson, WH, Leston, M, Anand, S, Okusi, C, Fan, X, Linley, E, Rowe, C, DArcangelo, S, Otter, AD, Ellis, J, Hobbs, FDR, Tzortziou-Brown, V, Zambon, M, Ramsay, M, Brown, KE, Amirthalingam, G, Andrews, NJ, de Lusignan, S, Lopez Bernal, J

End of 2022/23 season influenza vaccine effectiveness in primary care in Great Britain by Whitaker, HJ, Willam, N, Cottrell, S, Goudie, R, Andrews, N, Evans, J, Moore, C, Agrawal, U, Hassell, K, Gunson, R, Zitha, J, Anand, S, Sebastian-Pillai, P, Kalapotharakou, P, Okusi, C, Hoschler, K, Jamie, G, Kele, B, Hamilton, M, Couzens, A, Quinot, C, Pheasant, K, Byford, R, Marsh, K, Robertson, C, de Lusignan, S, Williams, C, Zambon, M, McMenamin, J, Watson, CH